
Align Technology (ALGN) Stock Forecast & Price Target
Align Technology (ALGN) Analyst Ratings
Bulls say
Align Technology's strong market position in the clear aligner sector is underscored by its over 90% market share and the treatment of more than 14 million patients with its flagship product, Invisalign. The company's year-over-year growth metrics, including a notable 8.3% increase in teen case starts and a 4.9% rise in new Invisalign case starts to 647.8k, illustrate robust demand and operational strength, particularly in the APAC and EMEA regions. Additionally, positive trends in revenue and operating margins, alongside a record performance in clear aligner cases, contribute to an optimistic outlook for Align Technology's financial trajectory moving forward.
Bears say
Align Technology has faced significant challenges with revenue visibility, contributing to a negative outlook due to disappointing average selling prices (ASP) which have declined for seven consecutive quarters. Despite strong growth in direct-to-consumer segments, the overall ASP pressure, down 3.9% year-over-year, raises concerns about the company's pricing power, especially given increased competition and potential market limitations in clear aligners. Furthermore, projected operating margins and future ASP declines point towards ongoing profitability concerns, exacerbated by potential economic headwinds that may impact patient demand for orthodontic treatments.
This aggregate rating is based on analysts' research of Align Technology and is not a guaranteed prediction by Public.com or investment advice.
Align Technology (ALGN) Analyst Forecast & Price Prediction
Start investing in Align Technology (ALGN)
Order type
Buy in
Order amount
Est. shares
0 shares